360° SearchNetwork Hot Spots Trends Time Series

Advanced Search Options >>

clinical study

Type: Keyphrase

Name: clinical study

First reported 8 hours ago - Updated 8 hours ago - 1 reports

MannKind Corp

Puma, Mannkind Among Week’s Biggest Movers

The Los Angeles Business Journal’s index of largest local public companies continued to gain this week, in line with the larger markets.The weighted LABJ Stock Index rose 1 percent to 169.07 for the trading week ending May 17. Gainers outpaced decliners ... [Published Los Angeles Business Journal - 8 hours ago]

Entities: MannKind Corp, antineoplastic, Bellisio Foods, Puma Biotechnology Inc

First reported 9 hours ago - Updated 9 hours ago - 1 reports

First Experience With a New IOL

The only glistening-free hydrophobic acrylic lens performs well in this surgeon's hands and in patients' eyes.In choosing an IOL, I look for predictability, reliability, and ease of use. I always tell the surgeons I am training that instruments and lenses ... [Published Cataract & Refractive Surgery Today - 9 hours ago]

Entities: Hydrophobic, Cataract, Intraocular Lens, Experience, Vacuoles

First reported 11 hours ago - Updated 11 hours ago - 1 reports

Parents heartbroken after experimental autism drug study canceled

NEWPORT NEWS -- Lori Armer was playing basketball with her 15-year-old son Friday in their Newport News backyard recently. He high-fived her after he made a basket and shrieked in elation.Until last October, Jonathan had never played basketball and Lori ... [Published WVEC - 11 hours ago]

Entities: Autism, Drugs, Therapeutics

First reported May 17 2013 - Updated 19 hours ago - 1 reports

1.5 Million Myocardial Infarctions Occur in the United States

Myocardial infarction (MI), is the technical term for heart attack. It is a result of temporary or reduced supply of blood to the heart muscle causing cell damage from lack of oxygen. This is due to the blockage of coronary artery.About 1/5 of myocardial ... [Published The Guardian Express - May 17 2013]

Entities: Myocardial Infarction, Patient, clinical study

First reported 21 hours ago - Updated 21 hours ago - 1 reports

Point-of-care immunoassay outperforms standard culture in Group A streptococcal infection diagnostics

ArcDia International : 17 May, 2013 (Company News)ArcDia International has released results from a clinical study comparing its rapid mariPOC test product to the standard bacterial culture in detection of Group A streptococcal infections.ArcDia International ... [Published Pro Health Service Zone - 21 hours ago]

Entities: immunoassay, Point-of-Care, Patient, infections, clinical study

First reported May 17 2013 - Updated 21 hours ago - 1 reports

2 melanoma drugs show promise in clinical study

In the study, 52 melanoma patients were simultaneously treated with Bristol-Myers melanoma drug Yervoy and nivolumab, its experimental therapy that targets the immune system in a different way. Tumors shrank in 40 percent of patients, and in 53 percent ... [Published Journal-Gazette - May 17 2013]

Entities: Skin Cancer, Drugs, Patient, Tumor, clinical study

First reported 23 hours ago - Updated 23 hours ago - 1 reports

A Clinical Study Shows the Theracurmin(R)'s Safety and Potential Role in Improving Quality of Life QOL of Pancreatic Cancer Patients

(NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Theravalues, Japan-based biotechnology innovator, announced that a recent phase I clinical trial on the pancreatic cancer patients using Theracurmin®, an enhanced form of curcumin that ... [Published NewsRX - 23 hours ago]

Entities: Pancreatic Cancer, clinical study, Patient

First reported May 17 2013 - Updated May 17 2013 - 1 reports

ADMA Biologics Reports 1Q 2013 Financial and Operational Results

ADMA Biologics, Inc. reported financial and operational results for the quarter ended March 31. In a release dated May 14, the Company said highlights include:-Commenced pivotal Phase III clinical study of RI-002 for the treatment of primary immune deficiency ... [Published Individual.com - May 17 2013]

Entities: Biologics, Phase III, clinical study, Administrative Expenses, Operating Expenses

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer

(NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced the initiation of a Phase 1b/2a clinical study of ISIS-STAT3(Rx) in patients with advanced metastatic hepatocellular carcinoma ... [Published NewsRX - May 17 2013]

Entities: Isis Pharmaceuticals Inc, Initiation (Cancer), clinical study, Liver Cancer, Patient

First reported May 17 2013 - Updated May 17 2013 - 1 reports

Draft EMA Guideline Sets Biosimilar Groundwork, Clinical Study Comparisons

The European Medicines Agency (EMA) on May 2 published draft guidelines aimed at facilitating global development of biosimilars and avoiding unnecessary repeats of clinical trials. According to the guideline, the EMA would be open to comparing a biosimilar ... [Published FDA News - May 17 2013]

Entities: European Medicines Agency, clinical study, In Vivo, Clinical trials

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Clinical Study on E Cigarettes by Greek Researchers Unveils DeltaScan.org

Greek Researchers reveals that E Cigarettes have no adverse effects on Cardiac Functions that Real Cigarettes has.Los Angeles, CA -- (SBWIRE) -- 05/16/2013 -- Greek Researchers has research recently on E Cigarettes, a favorite choice of millions smokers ... [Published SBWire - May 16 2013]

Entities: clinical study, Tobacco, Electronic Cigarette

First reported May 16 2013 - Updated May 16 2013 - 1 reports

Cavemen's diet may solve obesity today

THE Stone Age man may have had the answer to a healthy body shape. Scientists this week released results of a clinical study that suggests meals rich in nutrients and fibre inspired by our Palaeolithic ancestors are better at satisfying the appetite than ... [Published The Herald Online - May 16 2013]

Entities: Obesity, Diet, clinical study, Diabetes Type II

Quotes

...that causes warts is from close contact with family members or classmates, rather than from public places such as pools or communal showers.” (2) "Current recommendations on wart prevention focus primarily on public places such as swimming pools, [but] children often get warts from family members or classmates rather than from public spaces, [suggesting that] covering warts at home or at school could maybe be more helpful in preventing warts." - Dr. Sjoerd Bruggink, Leiden University Medical Center. (2)

Pediatrics: HPV Warts Spread from Parents to Kids; polyDNA Recommends Protecting Kids from HPV wi ... [Published PRWeb - 1 hour ago]

...and normal lipid flow began to resume, patients reported being less susceptible to dry eye symptoms, many claiming complete symptom relief. "If you only treat the symptoms of dry eye, patients will still require eye drops or other types of dry eye regimens. But if you treat the cause, which Lipiflow does, patients can by symptom free and sometimes stop using drops altogether" says Theodore Perl, M DD MedicalMedical Director of Corneal Associates of New Jersey

Corneal Associates of New Jersey Introduces a New Breakthrough Treatment for Dry Eye Disease [Published PRWeb - 1 hour ago]

"Our goal is to launch this new era of Alzheimer's re, establish the framework to test the range of promising prevention therapies, and find ones that work without losing a generation, says Reiman. "It is our hope and expectation that a scientific road to a world without Alzheimer's disease would travel through Arizona."

Alzheimer's from A to Z [Published Noodls - 8 hours ago]

More Content

sort by: Date \| Relevance
Why MannKind's Afrezza Will Succeed Where Pfize... [Published Seeking Alpha - 28 mins ago]
NanoCarrier Co., Ltd. (4571) - Pharmaceuticals ... [Published TransWorldNews - 28 mins ago]
Pediatrics: HPV Warts Spread from Parents to Ki... [Published PRWeb - 1 hour ago]
Corneal Associates of New Jersey Introduces a N... [Published PRWeb - 1 hour ago]
Free Trial Power Precision Lean Muscle Formula ... [Published Weight Watchers - 3 hours ago]
Puma, Mannkind Among Week’s Biggest Movers [Published Los Angeles Business Journal - 8 hours ago]
Alzheimer's from A to Z [Published Noodls - 8 hours ago]
First Experience With a New IOL [Published Cataract & Refractive Surgery Today - 9 hours ago]
Parents heartbroken after experimental autism d... [Published WVEC - 11 hours ago]
New vitamin-based anti-aging serum hits market [Published Drug Store News - 15 hours ago]
Ground-breaking study into peanut allergy [Published Food Standards Agency - 18 hours ago]
Isis Pharmaceuticals initiates Phase Ib/IIa hep... [Published Individual.com - 19 hours ago]
Synexus Celebrates International Clinical Trial... [Published Individual.com - 21 hours ago]
Point-of-care immunoassay outperforms standard ... [Published Pro Health Service Zone - 21 hours ago]
A Clinical Study Shows the Theracurmin(R)'s Saf... [Published NewsRX - 23 hours ago]
2 melanoma drugs show promise in clinical study [Published Journal-Gazette - May 17 2013]
Boston Scientific Schedule Of Major Events And ... [Published TheStreet.com - May 17 2013]
[Correspondence] EU Clinical Trials Regulation [Published Lancet - May 17 2013]
ADMA Biologics Reports 1Q 2013 Financial and Op... [Published Individual.com - May 17 2013]
Isis Pharmaceuticals Announces the Initiation o... [Published NewsRX - May 17 2013]
Cell Medica Announces Treatment of First Pediat... [Published NewsRX - May 17 2013]
Opexa Therapeutics Reports First Quarter 2013 F... [Published Individual.com - May 17 2013]
1.5 Million Myocardial Infarctions Occur in the... [Published The Guardian Express - May 17 2013]
Draft EMA Guideline Sets Biosimilar Groundwork... [Published FDA News - May 17 2013]
Duke University Medical Center Study Finds Prod... [Published NewsRX - May 17 2013]
NCBiotech Awards $2.59M in Quarter [Published North Carolina Biotechnology Center - May 17 2013]
Sequenom's Management Presents at Bank of Ameri... [Published Seeking Alpha - May 16 2013]
Nektar Therapeutics' President and CEO, Howard ... [Published ADVFN UK - May 16 2013]
Nektar Therapeutics' President and CEO, Howard ... [Published ADVFN India - May 16 2013]
Direct Flow Medical® Receives IDE Approval for ... [Published Business Wire - May 16 2013]

Blogs

sort by: Date \| Relevance
Publisher Liability Rejected By Philadelphia C.... [Published Drug and Device Law - May 16 2013] Some time ago we were highly critical of a potentially dangerous expansion of liability for failure to warn to publishers of medical literature.That’s right, publishers.In our prior post we went after Slater v. Hoffman-La Roche, Inc., 771 F. Supp.2d ...
Bringing trial data out of the shadows [Published PharmaGossip - May 13 2013] All sectors have their own mood music, unobtrusive much of the time, but occasionally brought to startling effect into the foreground, dominating all else. The pharmaceutical industry is no different, and at present there is one insistent theme: transparency. ...
The Daily Startup: Extreme Reach Funded as TV, ... [Published WSJ.com: Venture Capital Dispatch - May 10 2013] Top stories in today’s VentureWire: Art by Mike Lucas Extreme Reach has raised over $50 million from Spectrum Equity to grow its sales and make acquisitions that can bring it new customers. The Needham, Mass.-based company offers a range of software ...
Cell Medica Announces Treatment of First Pediat... [Published Pharma-Mag - May 09 2013] Cell Medica announced the treatment of the first patient in the ASPIRE Trial, an early stage Phase I/II clinical study investigating the safety and efficacy of Cytovir ADV for the treatment of adenovirus infections in immunosuppressed pediatric patients ...
Imperial Innovations Group plc. [Published Pharma-Mag - May 08 2013] Cell Medica Treats First Paediatric Patient in Clinical Trial of Cytovir ADV Imperial Innovations Group plc. (‘Innovations’ or ‘the Group’), a leading technology commercialisation and investment group, announces that portfolio company Cell Medica, a biotechnology ...

Press Releases

sort by: Date \| Relevance
Direct Flow Medical® Receives IDE Approval for ... [Published Business Wire - May 16 2013]
New Study Reports Key Findings for the ABThera™... [Published Business Wire - May 16 2013]
New Clinical Study Finds Masimo rainbow® Acoust... [Published PR Newswire: Health - May 16 2013]
Stem Cell Therapeutics Announces Completion of ... [Published PR inside - May 16 2013]
New data to be presented at the 2013 ASCO Annua... [Published PR inside - May 16 2013]